Background/aims-Tuberous sclerosis complex (TSC) has retinal and nonretinal ophthalmic manifestations. This study was designed to determine the prevalence of the ophthalmic manifestations and of refractive errors in a population of patients with TSC. Methods-179 patients identified were in a prevalence study of TSC in the south of England and 107 of these agreed to full ophthalmic examination which was successful in 100. Ophthalmic examination included examination of the eyelids, cover test, examination of the irides, dilation funduscopy using both direct and indirect ophthalmoscopy, and refraction using retinoscopy. Myopia was defined as a spherical equivalent <−0.5D and hyperopia as a spherical equivalent >+0.5D. Results-Retinal hamartomas were seen in 44 of the 100 patients. The commonest morphological type of hamartoma seen was the flat, translucent lesion in 31 of the 44 patients (70%). The multinodular "mulberry" lesion was seen in 24 of the 44 patients (55%) and the transitional type lesion was seen in four of the 44 patients (9%). Punched out areas of retinal depigmentation were seen in 39 of the 100 patients but only six of 100 controls. 27% of eyes were myopic, 22% were hyperopic, and 27% had astigmatism >0.75D. Of the non-retinal findings, 39 patients had angiofibromas of the eyelids, five had nonparalytic strabismus, and three had colobomas. Conclusion-Apart from the higher prevalence of flat retinal hamartomas, the findings of this study compare closely with previous large clinic based series of TSC patients. Refractive findings were similar to previous studies of a similarly aged non-TSC population. This is the first series to document the statistically significant association of punched out chorioretinal depigmentation with TSC and the authors believe that it should be looked for as an aid to diagnosis. (Br J Ophthalmol 2001;85:420-423) Tuberous sclerosis complex (TSC) is a multisystem disorder characterised by hamartomatous growths that can occur in almost any organ or tissue. The first description of TSC is usually attributed to Bourneville in 1880 1 and in 1908, Vogt described the classic triad of epilepsy, mental retardation, and adenoma sebaceum (now called angiofibromatosis).
Tuberous sclerosis complex (TSC) is a multisystem disorder characterised by hamartomatous growths that can occur in almost any organ or tissue. The first description of TSC is usually attributed to Bourneville in 1880 1 and in 1908, Vogt described the classic triad of epilepsy, mental retardation, and adenoma sebaceum (now called angiofibromatosis). 2 The clinical manifestations of TSC are now known to be far more diverse and a more inclusive system of primary and secondary diagnostic criteria have been introduced. 3 These include cortical tubers, retinal astrocytomas, facial angiofibromas, ungual fibromas, hypomelanotic skin lesions, shagreen patch, and renal angiomyolipomas.
Ophthalmic features associated with TSC can be divided into retinal and non-retinal. The retinal associations of TSC were first noted by Van der Hoeve in 1921. 4 He termed these lesions phakomas (derived from the greek phakos, meaning spot) and introduced the concept of phakomatosis. These retinal lesions are now known to be astrocytic hamartomas. 5 Three basic morphological types of retinal hamartomas are described in the literature 6 : (i) the relatively flat, smooth, non-calcified, grey, translucent lesion ( Fig 1A) ; (ii) the elevated, multinodular, calcified, opaque lesion resembling mulberries ( Fig 1B) ; and (iii) a transitional lesion which has morphological features of both of the previous. Other retinal findings include retinal pigmentary disturbance ranging from hyperpigmented areas (probably congenital retinal pigment epithelium hypertrophy) 7 to "punched out" hypopigmented areas at the posterior pole or midperiphery (Fig 1C) . 8 9 Non-retinal findings include angiofibromas of the eyelids, coloboma of the iris, lens and choroid, strabismus, poliosis of eyelashes, papilloedema, 7 and sector iris depigmentation. 9 Previous studies 6 8 10 11 have examined the prevalence of ophthalmic manifestations of TSC in clinic based studies in the USA and Japan, but this is the first population based study examining the prevalence in a UK based population.
Materials and methods
The study population encompassed Avon, Wiltshire, Southampton and south west Hampshire, Portsmouth and south east Hampshire, Winchester, and Dorset as part of the Wessex Tuberous Sclerosis epidemiology study undertaken by FJO. Multicentre ethics committee approval was obtained. Patients with TSC were identified by various methods: (i) written contact with consultants likely to encounter individuals with TSC, including paediatricians, neurologists, ophthalmologists, dermatologists, cardiologists, nephrologists, urologists, neurosurgeons, physicians in learning disorders, geneticists, and general practitioners; (ii) a review of the hospital activity analysis in the study area from 1986 onwards; (iii) information from the Tuberous Sclerosis Association (a support group for patients with TSC). The diagnosis of TSC was confirmed by FJO using the criteria of two independent hamartomas. 12 The total population in the study area was 3 679 162 (data from OYce of Populations, Census and Surveys, census date 1 August 1998) and from this, 179 patients with TSC were identified giving a prevalence of 4.9/ 100 000. Of these 179 patients, 107 agreed to undergo ophthalmic examination.
We performed ophthalmic examination of the eyelids, cover test, examination of the irides, dilated funduscopy using direct ophthalmoscopy and indirect ophthalmoscopy with 20D lens, and refraction of both eyes using retinoscopy. We classified the retinal hamartomas into the three categories previously described. In order that the refractive results could be compared with previous population studies, 13 14 myopia was classified as a spherical equivalent <−0.5D, hyperopia as a spherical equivalent >+0.5D, and emmetropia as a spherical equivalent between −0.5D and +0.5D. The ophthalmic examinations were all performed by one ophthalmologist (SAR).
Results
Of the 107 patients who agreed to undergo ophthalmic assessment, full retinal examination was possible in 100 with the other seven patients being unable to cooperate suYciently owing to their degree of mental impairment. The results which follow relate only to the 100 fully examined patients. The median age of the patients was 27 (range 2-76 years) with 50 male and 50 female patients. The association between age and retinal lesion was analysed by dividing age into quintiles and then using 2 analysis.
RETINAL FINDINGS
Retinal hamartomas were found in 44 patients and were bilateral in 15 patients (34%). In 13 patients (30%) there was more than one morphological type of hamartoma present.
The commonest morphological type of hamartoma seen in our series was the flat, smooth translucent lesion which was seen in 31 of the 44 patients (70%). Their sizes ranged from 0.25 to 2 disc diameters and they were usually at the posterior pole and frequently were seen to be superficial to retinal vessels.
The classic, multinodular, "mulberry" lesion was seen in 24 of the 44 patients (55%) and was the second commonest retinal hamartoma in our series. These were always located in the posterior pole and 80% were on or within 2 disc diameters of the optic disc. Their sizes ranged from 0.25 to 4 disc diameters. The third morphological type of retinal hamartoma, the transitional lesion with features of both of the previous types, was seen in four of the 44 patients (9%). In all cases, these were flat hamartomas with a central area of nodular calcification and were located at the posterior pole.
There was no correlation between age and the presence of retinal astrocytic hamartomas overall ( 2 1.8 with 4 df, p>0.5). When the individual type of retinal hamartoma was considered, there was again no correlation between age and the three types of retinal hamartoma ( 2 10.2 with 4 df, p>0.1). Punched out areas of chorioretinal hypopigmentation were seen in 39 of the 100 patients examined. The areas were all less than 1 disc diameter in size and were all located in the midperiphery of the retina. When 100 age matched, opportunistically collected, non-TSC controls attending general ophthalmic clinics at the Royal United Hospital were examined, hypopigmented areas were seen in 6/100 patients (SAR, unpublished data). Using the two sided Fisher exact test on our data, there is a statistically significant association between these lesions and TSC (p<0.001). There was no correlation between the presence of chorioretinal hypopigmentation and age ( 2 1.7 with 4 df, p>0.5).
Figure 1 (A) Smooth non-calcified retinal hamartoma (arrowed). (B) Calcified, multinodular retinal hamartomas ("mulberry tumours"). (C) "Punched out" areas of chorioretinal depigmentation. Ophthalmic manifestations of tuberous sclerosis 421
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NON-RETINAL FINDINGS
Angiofibromas of the eyelids were seen in 39 of the 100 patients and non-paralytic strabismus was seen in five patients (four exotropia and one esotropia). Colobomas were seen in three patients. One of these involved only the iris but the other two had iris and choroidal involvement. In two patients, sector depigmentation of the iris was present.
REFRACTION
Reliable refraction was possible in 80 of the 100 patients and in 10 patients, a recent refraction was taken from optometrists' records. As tropicamide 1% was used in the study, the refraction was not a true cycloplegic refraction. Myopia was present in 48/180 eyes (27%), hyperopia was present in 39/180 eyes (22%), and astigmatism (>0.75D) was present in 48/180 eyes (27%). Anisometropia (>1.0D diVerence between the two eyes) was found in 10 patients (11%).
Discussion
The prevalence of ophthalmic features of TSC has never been reported in a large population based study before. The prevalence of TSC associated retinal astrocytic hamartomas in previous clinic based studies varies from 3% 15 to 100%, 10 but the largest reported series from the Mayo Clinic 6 gives an overall prevalence of 49%. Comparisons of our series with previously reported large series of retinal findings in TSC are shown in Table 1 .
We found no correlation between age and type of retinal hamartoma which supports previous findings that most retinal lesions in tuberous sclerosis remain stable over time. 16 The commonly held belief that flat hamartomas evolve into the multinodular type is therefore likely to be incorrect.
Although "punched out" areas of chorioretinal depigmentation have been noted in previous series 6 10 17 their significance to TSC was uncertain. In a smaller series of patients from the same region, 17 they were seen in 15 of 19 patients with TSC and in none of 19 age and sex matched non-TSC controls. In our larger series, compared with an age matched non-TSC population, we have shown a statistically significant association between these lesions and TSC, and we believe that "punched out" areas of chorioretinal depigmentation could be used to aid diagnosis in patients suspected of having TSC. We found no correlation between age and these areas of chorioretinal depigmentation which was also found in the previous series. 17 Of the non-retinal findings, angiofibromas of the eyelids were the commonest being present in 39 of 100 patients. Non-paralytic strabismus was seen in five of 100 patients and colobomas were present in three patients, one involving iris alone and the other two also involving choroid.
This is the first study to report on the refraction of patients with TSC. The definitions of myopia and hyperopia were chosen so that comparisons could be made with previous data from normal populations. 13 14 The age of the patients in these studies, however, is older than our series and it is diYcult to make comparisons with similarly aged populations owing to diVering definitions of types of refractive error and diVering methods of refraction. Overall, 27% of eyes were myopic (<−0.5D), 22% of eyes were hyperopic (>+0.5D), and 51% were emmetropic. This compares with 25% myopia prevalence in the similarly aged sample from the National Health and Nutrition Examination Survey (NHANES), 18 15% myopia, and 57% hyperopia in the older sample from the Blue Mountains Eye Study, 13 and 26% myopia and 49% hyperopia in the older Beaver Dam study population.
14 In a similarly aged Finnish population 19 the prevalence of myopia was 11.5% and of hyperopia was 28.3%, although their definition was spherical equivalent of +2D or more. If this definition were applied to our population, the prevalence of hyperopia would be 8%.
Approximately 50% of TSC patients have some degree of mental impairment 20 and in our study population 35% had moderate to severe mental impairment. Given that myopia has been associated with educational achievement, 19 21 it is interesting to note that the prevalence of myopia in our sample of TSC patients is greater than that seen in other similarly aged normal populations.
The prevalence of astigmatism was 27% (0.5-4.5D) compared with 20% in Danish study of hospital patients aged 22 and 10% in the Finnish population above. 19 The prevalence of anisometropia (>1.25D diVerence between the two eyes) was 11% in our study compared with 7.1% in the Finnish study 19 and 9% in the Danish study. 22 In summary, this is the first population based study documenting the prevalence of ophthalmic manifestations in patients with TSC and the refraction of these patients. The fundal findings compare closely with previous large clinic based studies apart from a higher prevalence of flat hamartomas in our study group. This is also the 
